In order to study the practical impact of the new Quantifiler1
Trio Kit on our workflow, a set of 181 evidence samples from
adjudicated casework (oral swabs, blood, touch DNA, bones and
human remains, sperm and hair) were selected on the basis of the
DNA profile obtained during the first analysis. Only single profiles
and mixtures with a distinguishable major contributor were
selected with the aim of including a range of degrees of DNA
degradation